Summary
For Year 2026-27, Sotac Pharmaceuticals reports the following shareholding: Total Promoters at 72.85%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 16.14%, Domestic Institutional Investors at 0%, and Retail at 11.01%. This breakdown provides a quick snapshot of ownership distribution for Sotac Pharmaceuticals in 2026-27.
Sotac Pharmaceuticals FAQs
As of 04-2026, the promoter shareholding in Sotac Pharmaceuticals stands at 72.85% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Sotac Pharmaceuticals is 16.14% and 0% respectively.
The retail shareholding of the Sotac Pharmaceuticals is 11.01%.
Changes in shareholding patterns of Sotac Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Sotac Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Sotac Pharmaceuticals Associated Pages
- Sotac Pharmaceuticals Share Price
- Sotac Pharmaceuticals Share Price chart
- Sotac Pharmaceuticals Fundamental Analysis
- Sotac Pharmaceuticals Technical Analysis
- Sotac Pharmaceuticals Peer Comparison
- Sotac Pharmaceuticals Share Price History
- Sotac Pharmaceuticals Dividend
- Sotac Pharmaceuticals Board of Directors
